Skip to main content
. 2016 May 12;20(9):1729–1736. doi: 10.1111/jcmm.12879

Figure 3.

Figure 3

Kaplan–Meier survival analyses of rectal cancer patients receiving neoadjuvant CRT treatment according to FAK expression levels in pre‐treatment biopsies. Patients in the FAK expression group showed significantly better disease‐free survival than those in the no expression group. Data are based on immunohistochemical results of pre‐treatment biopsies.